These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 4597622)
21. Mechanism of lymphocyte-mediated cytolysis. The LMC cycle and its role in transplantation immunity. Berke G; Amos DB Transplant Rev; 1973; 17(0):71-107. PubMed ID: 4152005 [No Abstract] [Full Text] [Related]
23. Thymus-derived lymphocytes as effectors of cell-mediated immunity to syngeneic and allogeneic transplants in the rat. Tucker DF; Dennert G; Lennox ES J Immunol; 1974 Oct; 113(4):1302-12. PubMed ID: 4547337 [No Abstract] [Full Text] [Related]
24. Mechanism of blocking by hyperimmune serum of lymphocyte-mediated cytolysis of allogeneic tumor cells. Todd RF; Stulting RD; Berke G Cancer Res; 1973 Dec; 33(12):3203-8. PubMed ID: 4760536 [No Abstract] [Full Text] [Related]
25. Cell-mediated reactivity and serum blocking activity in tolerant rats. Studies on ten rats operationally tolerant to skin allografts using several independent assays. Wright PW; Bernstein ID; Hamilton B; Gluckman JC; HELLSTROM KE Transplantation; 1974 Jul; 18(1):46-55. PubMed ID: 4152086 [No Abstract] [Full Text] [Related]
29. Cellular and humoral immunity after allogeneic transplantation in the rat. 3. The effect of passive antibody on cellular and humoral immunity after allogeneic renal transplantation. Biesecker JL; Fitch FW; Rowley DA; Stuart FP Transplantation; 1973 Nov; 16(5):432-40. PubMed ID: 4584953 [No Abstract] [Full Text] [Related]
31. Oral cancer and immunity. Cannell H Br J Oral Surg; 1973 Nov; 11(2):171-6. PubMed ID: 4544850 [No Abstract] [Full Text] [Related]
32. Alloantiserum-mediated suppression of histocompatibility-linked IR gene controlled immune responses. I. Histocompatibility antigen requirement. Bluestein HG J Immunol; 1974 Nov; 113(5):1410-6. PubMed ID: 4417776 [No Abstract] [Full Text] [Related]
33. Specificity of 51Cr-release cytotoxicity of lymphocytes immune to murine sarcoma virus. Herberman RB; Aoki T; Nunn M; Lavrin DH; Soares N; Gazdar A; Holden H; Chang KS J Natl Cancer Inst; 1974 Oct; 53(4):1103-11. PubMed ID: 4139276 [No Abstract] [Full Text] [Related]
34. in vitro quantitation of lymphocyte and serum cytotoxic activity following renal homograft rejection in man. Wolf JS; Fawley JC; Hume DM Transplant Proc; 1971 Mar; 3(1):449-52. PubMed ID: 4937916 [No Abstract] [Full Text] [Related]
35. Studies on the effect of specific antisera on the metabolism of cellular antigens. II. The synthesis and degradation of TL antigens of mouse cells in the presence of TL antiserum. Yu A; Cohen EP J Immunol; 1974 Apr; 112(4):1296-307. PubMed ID: 4360860 [No Abstract] [Full Text] [Related]
36. Cellular and humoral factors governing canine mixed lymphocyte cultures after renal transplantation. I. Antibody. Miller J; Hattler B; Davis M; Johnson MC Transplantation; 1971 Jul; 12(1):65-76. PubMed ID: 4932699 [No Abstract] [Full Text] [Related]
37. Cell-mediated immune reactions to human tumors. Perlmann P; Troye M; Pape GR Cancer; 1977 Jul; 40(1 Suppl):448-57. PubMed ID: 69485 [No Abstract] [Full Text] [Related]
38. Histocompatibility in humans. Fotino M Ann Clin Lab Sci (1971); 1971; 1(2):125-30. PubMed ID: 4405210 [No Abstract] [Full Text] [Related]
39. Regulation of cell-mediated cytotoxicity. II. Synergism of two types of thymus dependent cells in vivo. Sabbadini E Cell Immunol; 1975 Jul; 18(1):76-87. PubMed ID: 237633 [No Abstract] [Full Text] [Related]